Validation of MMS Test for Cancer Monitoring (MMS-TM)

MedInnovation

Status: Terminated

Conditions: Sarcoma; Melanoma; Colo-rectal Cancer; Stomach Cancer

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT02113683

MMS-tm14

Details and patient eligibility

About

The purpose of this study is the validation of MMS test to detect active tumor growth in different cancer types before and after therapy, as well as in the course of therapy and for subsequent relapse control compared to standard methods (clinical examination, imaging, tumor markers). It should be consider whether the MMS test has comparable diagnostic accuracy, and thus can replace more expensive or invasive procedures in future.

Enrollment: 100 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinical diagnosis of colo-rectal cancer
• Clinical diagnosis of stomach cancer
• Suspected diagnosis of melanoma

Exclusion criteria

• Colitis ulcerosa
• Morbus Crohn
• Cancer in time period two years before
• Cancer therapy in time period two years before

Trial design

100 participants in 1 patient group

MMS test

Description:

therapy monitoring of patients with colo-rectal or stomach disease or with melanoma